...
首页> 外文期刊>Frontiers in Microbiology >Fused IgY Fc and Polysaccharide Adjuvant Enhanced the Immune Effect of the Recombinant VP2 and VP5 Subunits—A Prospect for Improvement of Infectious Bursal Disease Virus Subunit Vaccine
【24h】

Fused IgY Fc and Polysaccharide Adjuvant Enhanced the Immune Effect of the Recombinant VP2 and VP5 Subunits—A Prospect for Improvement of Infectious Bursal Disease Virus Subunit Vaccine

机译:融合的IgY Fc和多糖佐剂增强了重组VP2和VP5亚基的免疫效果-改善传染性法氏囊病病毒亚基疫苗的前景

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Infectious bursal disease virus (IBDV) is a highly contagious pathogen that causes damage in lymphoid organs and remains a threat to the poultry industry worldwide. Currently, subunit vaccines based on VP2 antigen expressed in prokaryotic systems are widely used in clinical settings. However, the immunogenicity of VP2 vaccines is limited because of their inherent defect that the structure of the antigen expressed in Escherichia coli ( E. coli ) may be different from its natural conformation. In this study, we fused VP2 and VP5 protective antigen genes and linked the chicken IgY Fc gene onto it. The eukaryotic expression plasmid carrying the fusion gene was transformed into Pichia pastoris ( P. pastoris ) to express the recombinant VP2–VP5–Fc protein. The recombinant protein was used as immunogen for evaluating immune response, and the recombinant VP2–Fc and VP2 proteins expressed in P. pastoris and the commercial VP2 subunit vaccines were used as controls. Moreover, Taishan Pinus massoniana pollen polysaccharide (TPPPS), an immunomodulator found by our laboratory, was used as adjuvant to investigate its immune modulatory effects on immunogens. Chickens were divided into six groups and inoculated with VP2–VP5–Fc+TPPPS, VP2–VP5–Fc, VP2–Fc, VP2 vaccine, commercial VP2 subunit vaccine, and phosphate buffered saline (PBS). The recombinant VP2 subunit vaccine expressed in P. pastoris exhibited higher immunogenicity than the commercial VP2 subunit vaccine. The VP2–Fc protein showed a better effect than the VP2 protein, and the VP2–VP5–Fc subunit further improved the immune effects. In addition, TPPPS was proved to be a good immunopotentiator for the VP2–VP5–Fc subunit vaccine. Hence, the recombinant VP2–VP5–Fc subunit combined with TPPPS adjuvant exhibits potential as efficient IBDV vaccine to prevent infectious bursal disease.
机译:传染性法氏囊病病毒(IBDV)是一种具有高度传染性的病原体,会导致淋巴器官受损,并仍然威胁着全球家禽业。当前,基于在原核系统中表达的VP2抗原的亚单位疫苗被广泛用于临床环境。然而,由于VP2疫苗的固有缺陷,即在大肠杆菌(E.coli)中表达的抗原的结构可能与其天然构象不同,因此其免疫原性受到限制。在这项研究中,我们融合了VP2和VP5保护性抗原基因,并将鸡IgY Fc基因连接到其上。携带融合基因的真核表达质粒被转化到巴斯德毕赤酵母中,以表达重组VP2-VP5-Fc蛋白。重组蛋白用作评估免疫反应的免疫原,重组巴斯德毕赤酵母和商业VP2亚基疫苗中表达的VP2-Fc和VP2蛋白用作对照。此外,我们实验室发现的免疫调节剂泰山马尾松花粉多糖(TPPPS)被用作佐剂来研究其对免疫原的免疫调节作用。将鸡分为六组,分别接种VP2-VP5-Fc + TPPPS,VP2-VP5-Fc,VP2-Fc,VP2疫苗,商业VP2亚基疫苗和磷酸盐缓冲液(PBS)。在巴斯德毕赤酵母中表达的重组VP2亚单位疫苗显示出比商业VP2亚单位疫苗更高的免疫原性。 VP2-Fc蛋白显示出比VP2蛋白更好的效果,而VP2-VP5-Fc亚基进一步提高了免疫效果。此外,TPPPS被证明是VP2-VP5-Fc亚基疫苗的良好免疫增强剂。因此,重组VP2-VP5-Fc亚基与TPPPS佐剂结合显示出作为预防传染性法氏囊病的有效IBDV疫苗的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号